Analyst Price Targets — CNMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 1, 2025 1:26 pm | Mike Matson | Needham | $61.00 | $57.19 | TheFly | Conmed price target lowered to $61 from $91 at Needham |
| October 4, 2024 9:04 am | Mike Matson | Needham | $97.00 | $66.59 | StreetInsider | Needham Reiterates Buy Rating on CONMED (CNMD) |
| April 25, 2024 9:46 am | Matt O\'Brien | Piper Sandler | $95.00 | $64.34 | StreetInsider | CONMED (CNMD) PT Lowered to $95 at Piper Sandler |
| April 25, 2024 7:28 am | Mike Matson | Needham | $107.00 | $70.01 | StreetInsider | CONMED (CNMD) PT Lowered to $107 at Needham |
| October 26, 2022 8:00 pm | Matt O'Brien | Piper Sandler | $108.00 | $83.39 | TheFly | Conmed price target lowered to $108 from $118 at Piper Sandler |
Latest News for CNMD
On April 14, 2026, Conmed Corp (CNMD) shares rose 3.3% to a current price of $39.73. The stock is trading within a 52-week range of $33.21 to $61.08, reflecting
CNMD's high-margin platforms, supply-chain recovery and margin expansion plans support growth, though tariffs and portfolio shifts weigh on near-term results.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number…
Shares of CONMED Corporation (NYSE: CNMD - Get Free Report) have earned an average rating of "Reduce" from the eight analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and seven have issued a hold recommendation on the company. The average 12 month price
CNMD's growth rests on AirSeal, Buffalo Filter and BioBrace as supply chains normalize, even as tariffs and a GI exit pressure EPS.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CNMD.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.